+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psoriasis Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
From
From
From
Acthar Gel - API Insight, 2022 - Product Thumbnail Image

Acthar Gel - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Humira- Drug Insight, 2019 - Product Thumbnail Image

Humira- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Acthar Gel- Drug Insight, 2019 - Product Thumbnail Image

Acthar Gel- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Taltz- Drug Insight, 2019 - Product Thumbnail Image

Taltz- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
AbbVie Hit Harder By EU Humira Biosimilars Than Projected - Product Thumbnail Image

AbbVie Hit Harder By EU Humira Biosimilars Than Projected

  • Newsletter
  • May 2024
  • 3 Pages
  • Europe
From
From
Stelara - Product Thumbnail Image

Stelara

  • Report
  • August 2018
  • 57 Pages
  • Global
From
Loading Indicator

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms. The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more